3VN2

Crystal Structure of PPARgamma complexed with Telmisartan


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.18 Å
  • R-Value Free: 0.309 
  • R-Value Work: 0.250 
  • R-Value Observed: 0.253 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Structural basis for telmisartan-mediated partial activation of PPAR gamma

Amano, Y.Yamaguchi, T.Ohno, K.Niimi, T.Orita, M.Sakashita, H.Takeuchi, M.

(2012) Hypertens Res 35: 715-719

  • DOI: 10.1038/hr.2012.17
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • Telmisartan, a selective angiotensin II type 1 receptor blocker, has recently been shown to act as a partial agonist for peroxisome proliferator-activated receptor gamma (PPARγ). To understand how telmisartan partially activates PPARγ, we determined ...

    Telmisartan, a selective angiotensin II type 1 receptor blocker, has recently been shown to act as a partial agonist for peroxisome proliferator-activated receptor gamma (PPARγ). To understand how telmisartan partially activates PPARγ, we determined the ternary complex structure of PPARγ, telmisartan, and a coactivator peptide from steroid receptor coactivator-1 at a resolution of 2.18 Å. Crystallographic analysis revealed that telmisartan exhibits an unexpected binding mode in which the central benzimidazole ring is engaged in a non-canonical--and suboptimal--hydrogen-bonding network around helix 12 (H12). This network differs greatly from that observed when full-agonists bind with PPARγ and prompt high-coactivator recruitment through H12 stabilized by multiple hydrogen bonds. Binding with telmisartan results in a less stable H12 that in turn leads to attenuated coactivator binding, thus explaining the mechanism of partial activation.


    Organizational Affiliation

    Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan.



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Peroxisome proliferator-activated receptor gamma
A
285Homo sapiensMutation(s): 0 
Gene Names: PPARGNR1C3
Find proteins for P37231 (Homo sapiens)
Go to UniProtKB:  P37231
NIH Common Fund Data Resources
PHAROS  P37231
  • Find similar proteins by: Sequence   |   Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
Nuclear receptor coactivator 1
C
16Homo sapiensMutation(s): 0 
Gene Names: NCOA1BHLHE74SRC1
EC: 2.3.1.48
Find proteins for Q15788 (Homo sapiens)
Go to UniProtKB:  Q15788
NIH Common Fund Data Resources
PHAROS  Q15788
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
TLS
Query on TLS

Download CCD File 
A
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
C33 H30 N4 O2
RMMXLENWKUUMAY-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
TLSEC50:  3400   nM  BindingDB
TLSEC50:  700   nM  BindingDB
TLSEC50:  1520   nM  BindingDB
TLSEC50:  4500   nM  BindingDB
TLSEC50:  4700   nM  BindingDB
TLSEC50:  4710   nM  BindingDB
TLSEC50:  4970   nM  BindingDB
TLSIC50:  12200   nM  BindingDB
TLSEC50:  4060   nM  BindingDB
TLSEC50:  2020   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.18 Å
  • R-Value Free: 0.309 
  • R-Value Work: 0.250 
  • R-Value Observed: 0.253 
  • Space Group: P 21 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 132.852α = 90
b = 53.499β = 90
c = 53.86γ = 90
Software Package:
Software NamePurpose
HKL-2000data collection
MOLREPphasing
REFMACrefinement
HKL-2000data reduction
HKL-2000data scaling

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2011-12-21 
  • Released Date: 2012-03-07 
  • Deposition Author(s): Amano, Y.

Revision History 

  • Version 1.0: 2012-03-07
    Type: Initial release
  • Version 1.1: 2013-07-17
    Changes: Database references